Abbott Stock Surges on Strong Q4 Results and Positive Outlook

Generado por agente de IAMarcus Lee
jueves, 23 de enero de 2025, 3:19 pm ET1 min de lectura
ABT--


Abbott Laboratories' stock price surged by 3.7% on Thursday, January 24, 2025, following the company's strong fourth-quarter results and positive outlook for the future. The company reported sales of $10.97 billion, up 7.2% year over year, and organic sales growth of 8.8% for the underlying base business. Stifel analyst Rick Wise has a positive outlook on Abbott's Q4 2024 results and its 2025 projections, seeing strong momentum in the Diabetes Care and Structural Heart segments.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios